News


GLOBE NEWSWIRE

CicloMed Announces ASCO 2018 Presentation on Clinical Trial for Ciclopirox Prodrug, Under Development for Bladder Cancer

5/31/2018

FIERCE BIOTECH

Antifungal ‘prodrug’ shows promise in bladder cancer: AACR

4/16/2018

GLOBE NEWSWIRE

CicloMed Announces Presentation of Preclinical Evidence for its Bladder Cancer Agent at AACR 2018 Meeting

4/12/2018

DRUG DEVELOPMENT & DELIVERY

CicloMed Announces First Patient Dosed With Ciclopirox Prodrug in Phase I Trial

3/6/2018

 

GLOBE NEWSWIRE

CicloMed Announces First Patient Dosed with Ciclopirox Prodrug in Phase I Trial in Patients with Advanced Solid Tumors

2/28/2018

 

The University of Kansas Cancer Center

CicloMed Announces FDA Clearance of IND Application for Ciclopirox Prodrug in the Treatment of Bladder Cancer

10/11/2017

University of kansas medical center

IAMI partners with BioNovus to develop bladder cancer drug

5/9/2016

GLOBE NEWSWIRE

FDA gives CicloMed permission to proceed to phase I clinical trials of Ciclopirox Prodrug in cancer patients with advanced solid tumors

10/11/2017

 

Kansas City business journal

KC biotech developing KU cancer drug clears big FDA hurdle

10/11/2017

 

Scientific Publications


 ASCO 2018 POSTER

Title: Safety, Dose Tolerance, Pharmacokinetics and Pharmacodynamics Study of CPX-POM in Patients with Advanced Solid Tumors

Date 6/4/2018

ASCO 2018 ABSTRACT TPS2618

Title: Safety, Dose Tolerance, Pharmacokinetics and Pharmacodynamics Study of CPX-POM in Patients with Advanced Solid Tumors

Date 6/4/2018

AACR 2018 POSTER

Bench-to-Bedside Translation of Ciclopirox Prodrug for the Treatment of

Non-Muscle Invasive and Muscle-Invasive Bladder Cancer

4/18/2018

AACR 2018: ABSTRACT 5882

Bench-to-bedside translation of ciclopirox prodrug for the treatment of non-muscle invasive and muscle-invasive bladder cancer

4/18/2018

ALBERT INSTITUTE

Product Development-Focused Translational Research: A Collaboration Model to Bring New Treatments to Bladder Cancer Patients

9/15/2017

DRUG REPOSITIONING CONFERENCE

Public-Private Partnership to Bring New Treatments to Patients

6/28/2017

AACR 2015: ABSTRACT 1895

Ciclopirox prodrug for the prevention and therapy of non-muscle invasive bladder cancer

4/18/2015

 

Additional Resources


Bladder Cancer Advocacy Network (BCAN) – devoted to advancing bladder cancer research and supporting those impacted by the disease     

Leo and Anne Albert Institute for Bladder Cancer Care and Research – with the mission to advance knowledge of bladder cancer and the care of those with the disease    

Institute for Advancing Medical Innovation (IAMI) – Changing the standard of care for pediatric, adolescent and adult patients living with diseases including cancer and rare diseases    

The University of Kansas Cancer Center

Working toward a world without cancer, through world-class research, partnerships and patient care